These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34330289)

  • 1. Expression of the human molecular chaperone domain Bri2 BRICHOS on a gram per liter scale with an E. coli fed-batch culture.
    Schmuck B; Chen G; Pelcman J; Kronqvist N; Rising A; Johansson J
    Microb Cell Fact; 2021 Jul; 20(1):150. PubMed ID: 34330289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant BRICHOS chaperone domains delivered to mouse brain parenchyma by focused ultrasound and microbubbles are internalized by hippocampal and cortical neurons.
    Galan-Acosta L; Sierra C; Leppert A; Pouliopoulos AN; Kwon N; Noel RL; Tambaro S; Presto J; Nilsson P; Konofagou EE; Johansson J
    Mol Cell Neurosci; 2020 Jun; 105():103498. PubMed ID: 32389804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cytoskeletal proteins as binding partners of Bri2 BRICHOS domain.
    Shimozawa M; Tigro H; Biverstål H; Shevchenko G; Bergquist J; Moaddel R; Johansson J; Nilsson P
    Mol Cell Neurosci; 2023 Jun; 125():103843. PubMed ID: 36935047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dementia-related Bri2 BRICHOS is a versatile molecular chaperone that efficiently inhibits Aβ42 toxicity in Drosophila.
    Poska H; Haslbeck M; Kurudenkandy FR; Hermansson E; Chen G; Kostallas G; Abelein A; Biverstål H; Crux S; Fisahn A; Presto J; Johansson J
    Biochem J; 2016 Oct; 473(20):3683-3704. PubMed ID: 27514716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain and blood-cerebrospinal fluid passage of BRICHOS domains from two molecular chaperones in mice.
    Tambaro S; Galan-Acosta L; Leppert A; Chen G; Biverstål H; Presto J; Nilsson P; Johansson J
    J Biol Chem; 2019 Feb; 294(8):2606-2615. PubMed ID: 30598503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Bri3 BRICHOS domain is a molecular chaperone with effect against amyloid formation and non-fibrillar protein aggregation.
    Poska H; Leppert A; Tigro H; Zhong X; Kaldmäe M; Nilsson HE; Hebert H; Chen G; Johansson J
    Sci Rep; 2020 Jun; 10(1):9817. PubMed ID: 32555390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for different substrate-binding sites and chaperone functions of the BRICHOS domain.
    Chen G; Wang Y; Zheng Z; Jiang W; Leppert A; Zhong X; Belorusova A; Siegal G; Jegerschöld C; Koeck PJB; Abelein A; Hebert H; Knight SD; Johansson J
    Protein Sci; 2024 Jul; 33(7):e5063. PubMed ID: 38864729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthesis and characterization of Bri2 BRICHOS coated magnetic particles and their application to protein fishing: Identification of novel binding proteins.
    Tigro H; Kronqvist N; Abelein A; Galan-Acosta L; Chen G; Landreh M; Lyashkov A; Aon MA; Ferrucci L; Shimmo R; Johansson J; Moaddel R
    J Pharm Biomed Anal; 2021 May; 198():113996. PubMed ID: 33690096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalization of amyloid fibrils via the Bri2 BRICHOS domain.
    Biverstål H; Kumar R; Schellhaus AK; Sarr M; Dantuma NP; Abelein A; Johansson J
    Sci Rep; 2020 Dec; 10(1):21765. PubMed ID: 33303867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibition of α-synuclein oligomer generation and toxicity by the chaperone domain Bri2 BRICHOS.
    Adam L; Kumar R; Arroyo-Garcia LE; Molenkamp WH; Nowak JS; Klute H; Farzadfard A; Alkenayeh R; Nielsen J; Biverstål H; Otzen DE; Johansson J; Abelein A
    Protein Sci; 2024 Aug; 33(8):e5091. PubMed ID: 38980078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of glycolytic proteins as binding partners of Bri2 BRICHOS domain.
    Tigro H; Shimozawa M; Nilsson P; Lyashkov A; Khadeer M; Järving I; Ferrucci L; Shimmo R; Johansson J; Moaddel R
    J Pharm Biomed Anal; 2023 Aug; 232():115465. PubMed ID: 37220701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells.
    Oskarsson ME; Hermansson E; Wang Y; Welsh N; Presto J; Johansson J; Westermark GT
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2752-E2761. PubMed ID: 29507232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bri2 BRICHOS chaperone rescues impaired fast-spiking interneuron behavior and neuronal network dynamics in an AD mouse model in vitro.
    Andrade-Talavera Y; Chen G; Kurudenkandy FR; Johansson J; Fisahn A
    Neurobiol Dis; 2021 Nov; 159():105514. PubMed ID: 34555537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bri2 BRICHOS client specificity and chaperone activity are governed by assembly state.
    Chen G; Abelein A; Nilsson HE; Leppert A; Andrade-Talavera Y; Tambaro S; Hemmingsson L; Roshan F; Landreh M; Biverstål H; Koeck PJB; Presto J; Hebert H; Fisahn A; Johansson J
    Nat Commun; 2017 Dec; 8(1):2081. PubMed ID: 29234026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRICHOS domain associated with lung fibrosis, dementia and cancer--a chaperone that prevents amyloid fibril formation?
    Willander H; Hermansson E; Johansson J; Presto J
    FEBS J; 2011 Oct; 278(20):3893-904. PubMed ID: 21668643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-independent molecular chaperone activity generated under reducing conditions.
    Leppert A; Chen G; Lianoudaki D; Williams C; Zhong X; Gilthorpe JD; Landreh M; Johansson J
    Protein Sci; 2022 Aug; 31(8):e4378. PubMed ID: 35900025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A9 amyloid growth and S100A9 fibril-induced impairment of gamma oscillations in area CA3 of mouse hippocampus ex vivo is prevented by Bri2 BRICHOS.
    Andrade-Talavera Y; Chen G; Pansieri J; Arroyo-García LE; Toleikis Z; Smirnovas V; Johansson J; Morozova-Roche L; Fisahn A
    Prog Neurobiol; 2022 Dec; 219():102366. PubMed ID: 36273719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Bri2 and Bri3 BRICHOS Domains Interact Differently with Aβ
    Dolfe L; Tambaro S; Tigro H; Del Campo M; Hoozemans JJM; Wiehager B; Graff C; Winblad B; Ankarcrona M; Kaldmäe M; Teunissen CE; Rönnbäck A; Johansson J; Presto J
    J Alzheimers Dis Rep; 2018 Feb; 2(1):27-39. PubMed ID: 30480246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of Bri2 molecular chaperone activity against amyloid-β reduces neurotoxicity in mouse hippocampus in vitro.
    Chen G; Andrade-Talavera Y; Tambaro S; Leppert A; Nilsson HE; Zhong X; Landreh M; Nilsson P; Hebert H; Biverstål H; Fisahn A; Abelein A; Johansson J
    Commun Biol; 2020 Jan; 3(1):32. PubMed ID: 31959875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combinatorial approach of N-terminus blocking and codon optimization strategies to enhance the soluble expression of recombinant hIL-7 in E. coli fed-batch culture.
    Devi N; Adivitiya ; Khasa YP
    Appl Microbiol Biotechnol; 2016 Dec; 100(23):9979-9994. PubMed ID: 27342246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.